Effective Therapeutic Intervention for Left Atrial Appendage Thrombus: Percutaneous Left Atrial Appendage Closure

Objective: The thrombus formation in the left atrial appendage (LAA) can be challenging for operators and increases periprocedural complication risk. However, recent consensus documents discuss that closure is a potential therapeutic option malign appendage. This clinical study aimed to evaluate procedural safety early efficacy outcomes of patients with thrombus. Methods: observational single-center trial included 18 Transesophageal echocardiography was performed before during all patients. All procedures were using Amplatzer Amulet device (Abbott Medical Inc.). Results: Ten male (55.6%). mean ages 69.6 ± 7.5 years. CHA2DS2-VASc HAS-BLED scores calculated at 5 (2-8) 3 (1-6), respectively. In 4 (22.2%), occlusion indicated due significant bleeding event under oral anticoagulant treatment main indication 12 (66.7%). referred Transthoracic Echocardiography (TTE) transesophageal 30 days after procedure. There no major or minor adverse events first month follow-up. Also, patient faced ischemic cerebrovascular events, including transient attack, hospitalization heart failure, events. Neither device-related nor peridevice leak observed evaluation. Conclusions: Left feasible effective method reduce thromboembolic It as an alternative therapy anticoagulants (OACs) contraindications OACs